Labcorp has been selected as the winning bidder in the bankruptcy court-supervised sale of medical genetics company Invitae. The laboratory services giant will pay $239 million in cash to acquire most ...
BURLINGTON, N.C. and SAN FRANCISCO, May 7, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and Invitae (OTC:NVTAQ), a leading medical ...
Workplaces are changing, and in the case of medical genetic testing company Invitae, that meant taking 125,000 sq ft of a former outlet mall built in 1981 and transforming it into an advanced, ...
SAN FRANCISCO, April 5, 2021 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced it has entered into a definitive agreement to acquire Genosity Inc. ("Genosity"), ...
SAN FRANCISCO--(BUSINESS WIRE)--Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that it has expanded its genetic testing offering with hundreds of additional genes and ...
(MENAFN- PR Newswire) SAN FRANCISCO, June 3, 2021 /PRNewswire/ -- (NYSE: ), a leading medical genetics company, today announced it has begun offering early access to its new Personalized Cancer ...
Invitae, a San Francisco-based genetic tech company, announced it is laying off more than 700 employees at its headquarters. The layoffs at Invitae are part of a larger corporate restructuring in ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Invitae rolled up several ...
(Reuters) - Laboratory service provider Labcorp said on Wednesday it will acquire Softbank-backed Invitae Corp's assets auctioned through a voluntary bankruptcy protection process, a few months after ...
Another biotech company has announced it is coming to the Triangle. Invitae Corp., a medical genetics company based in San Francisco, plans to build a testing and laboratory in Morrisville, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results